Position in NTLA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$26,501,785
+$10,680,303 QoQ
Shares Held
2,067,222
+17.5% QoQ
Ownership
1.48%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,682,018,247 across 354 Biotechnology names. NTLA ranks #120 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in NTLA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26,501,785 | 2,067,222 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $15,821,482 | 1,759,898 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $31,989,082 | 1,852,292 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $14,262,739 | 1,520,548 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $11,307,046 | 1,590,302 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $14,608,102 | 1,252,839 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $48,077,175 | 2,339,522 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $49,871,992 | 2,228,418 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $60,696,466 | 2,206,342 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $36,179,523 | 1,186,603 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $47,209,542 | 1,493,028 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $61,574,251 | 1,509,913 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $44,934,835 | 1,205,657 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $84,501,904 | 2,421,952 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $146,993,095 | 2,626,753 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $171,087,812 | 3,305,406 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $203,107,198 | 2,794,925 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $458,507,877 | 3,877,773 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $426,646,365 | 3,180,368 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $441,820,331 | 2,728,802 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $92,372,621 | 1,150,989 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $69,763,974 | 1,282,426 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $27,413,803 | 1,378,964 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $33,813,423 | 1,608,631 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $10,172,228 | 831,744 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||